Morepen Laboratories Limited announced on Saturday, March 29, 2025, that it has entered into a loan agreement with Shinhan Bank for a term loan facility of Rs 25 crore. The company confirmed that the funds will be utilized for general business purposes as part of its ongoing expansion and operational strategies.
The loan carries an interest rate of 9.25% per annum (floating, repo-linked) and will be repaid in 10 equal quarterly installments after a 6-month moratorium period. The tenure of the loan is 36 months.
The loan facility is backed by a personal guarantee from Mr. Sushil Suri, Promoter, Chairman & Managing Director of the company. However, no equity dilution is involved as the agreement does not include any issuance of shares.
As per the company’s disclosure, Morepen Laboratories’ total outstanding loan (excluding this one) stands at Rs 48.50 crore, in addition to Rs 7.62 crore in vehicle loans and Rs 12.11 crore as loans against fixed deposits.
This strategic financial move is expected to strengthen the company’s working capital and enhance its operational efficiency, though the company has not indicated any material impact on its shareholding structure or board governance.
Disclaimer: The information provided in this article is based on official disclosures made by the company to stock exchanges. It is intended solely for informational purposes and should not be construed as financial or investment advice. Stock market investments are subject to market risks. Readers are advised to consult with a qualified financial advisor before making any investment decisions. Neither the author nor the publication is responsible for any losses incurred based on the information provided.
